We confirmed the AR-GATA3 interaction in cell line models, showed the interaction increased upon treatment with androgen, and detected AR-GATA3 interactions in primary clinical breast cancers as well as non-malignant human breast tissues. The gene discussed is GATA3; the disease is breast cancer.